InTouch looks to expand after acquisition
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Don’t touch and go: Allthenticate prepares offices and workers for safe returns
Businesses are searching for ways to reduce touchpoints in the wake of the coronavirus pandemic, and one Goleta cybersecurity firm has a touch-free technology that could answer the call. UC Santa Barbara startup Allthenticate has netted $500,000 in venture capital to fund the rollout of cell phone software and smart door readers that allows access Read More →
Read More →With IPO on shelf, Carpinteria’s Procore trims staff
Construction companies facing more than their usual share of cyclical uncertainty are turning in larger numbers than ever to software solutions that promise efficiency, creating new opportunities for firms like Procore. However, Carpinteria-based Procore recently announced the layoff of dozens of workers, the latest in a series of steps it has taken to respond to Read More →
Read More →Pandemic has silver lining for Trade Desk
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Inogen revenue falls, but Q2 earnings beat analyst estimates
The COVID-19 pandemic continued to cut into Inogen’s revenue, as new physician referrals and patient mobility declined during a quarter usually marked by increased patient travel and demand. Revenue fell nearly 30 percent in the second quarter to $71.7 million, missing average analyst estimates, and net income of $2.7 million was down from $9.9 million Read More →
Read More →Amgen teams up with competitors in COVID treatment trial
Amgen has joined two of its competitors in launching a trial for drugs to treat patients with COVID-19. Together with Chicago-based AbbVie and Japanese drugmaker Takeda Pharmaceutical, the Thousand Oaks biotech giant said Aug. 3 it had enrolled the first patients into a clinical trial for the anti-inflammatory drugs Otezla, cenicriviroc and Firazyr. Otezla is Read More →
Read More →Merger comes at a healthy time for Teladoc
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Sponsored content:
2015-2016 Giving Guide
